KV Pharma – Closed
We sold out of our investment in KV Pharma. Although we still believe the company is undervalued and will appreciate once it fixes the FDA issues, there are many investment opportunities that have a better risk/reward scenarios.
We took the proceeds from this investment and purchased more Caraco shares. We believe Caraco’s FDA issues will be fixed much sooner than KV Pharma and that the Caraco valuation will adjust once these issues are resolved.